Annals of oncology : official journal of the European Society for Medical Oncology
-
Multicenter Study
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
Optimal frontline therapy for peripheral T-cell lymphoma (PTCL) in the modern era remains unclear. ⋯ This analysis identifies early-stage disease and initial treatment response as dominant prognostic factors in PTCL. No clear benefit was observed for patients undergoing consolidative SCT. Novel therapeutic approaches for PTCL are critically needed.